You have 9 free searches left this month | for more free features.

human leukocyte antigen

Showing 26 - 50 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Leukemia, Myeloid, Acute Trial in Canada, United States (VOR33, Mylotarg)

Recruiting
  • Leukemia, Myeloid, Acute
  • La Jolla, California
  • +8 more
Jan 31, 2023

Resected Pancreatic Adenocarcinoma

Completed
  • Pancreatic Cancer Resectable
  • Multigene panel for next-generation sequencing
  • Shanghai, Shanghai, China
    Ruijin Hospital
Jul 31, 2022

Sars-CoV-2 Infection, COVID-19 Trial in Knoxville (Rapid SARS-CoV-2 Antigen Test)

Completed
  • Sars-CoV-2 Infection
  • COVID-19
  • Rapid SARS-CoV-2 Antigen Test
  • Knoxville, Tennessee
    EDP Biotech Corporation
Oct 14, 2022

Renal Cell Carcinoma, NSCLC, Pancreatic Adenocarcinoma, Colorectal Cancer Trial (RO7515629, tocilizumab)

Not yet recruiting
  • Renal Cell Carcinoma, Non-small Cell Lung Cancer, Pancreatic Adenocarcinoma, Colorectal Cancer
  • (no location specified)
Mar 3, 2023

Roles of Some Non-classic Biomarkers in Pediatric Pneumonia

Not yet recruiting
  • Pneumonia in Children
    • (no location specified)
    Jan 25, 2023

    Warts, Human Papilloma Virus Trial in Zagazig (Candida antigen vaccine, Bivalent HPV vaccine)

    Recruiting
    • Warts
    • Human Papilloma Virus
    • Candida antigen vaccine
    • Bivalent HPV vaccine
    • Zagazig, Al Sharqia, Egypt
      Reham Essam
    Jul 26, 2022

    Non Hodgkin Lymphoma, Acute Lymphoblastic Leukemia, Chronic Lymphocytic Leukemia Trial in Cleveland (Fully human anti CD19 CAR-T

    Recruiting
    • Non Hodgkin Lymphoma
    • +2 more
    • Fully human anti CD19 CAR-T Cell Dose
    • +2 more
    • Cleveland, Ohio
      University Hospitals Cleveland Medical Center, Case Comprehensiv
    Oct 4, 2022

    Lupus Nephritis, Lupus Nephritis - World Health Organization (WHO) Class III, Lupus Nephritis - WHO Class IV Trial in Denver,

    Recruiting
    • Lupus Nephritis
    • +2 more
    • KYV-101 anti-CD19 CAR-T cell therapy
    • Standard lymphodepletion regimen
    • Denver, Colorado
    • +1 more
    Jul 7, 2023

    Multiple Sclerosis, Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Secondary Progressive Trial in Palo Alto

    Not yet recruiting
    • Multiple Sclerosis
    • +2 more
    • KYV-101 anti-CD19 CAR-T cell therapy
    • Standard lymphodepletion regimen
    • Palo Alto, California
      Stanford Multiple Sclerosis Center
    Nov 13, 2023

    Chronic GVHD, Hematologic and Lymphocytic Disorder, Steroid Refractory GVHD Trial in Duarte (procedure, biological, other)

    Not yet recruiting
    • Chronic Graft Versus Host Disease
    • +2 more
    • Biopsy
    • +11 more
    • Duarte, California
      City of Hope Medical Center
    Aug 7, 2023

    Phase Angle and Chronic Intestinal Inflammatory Diseases

    Recruiting
    • Inflammatory Bowel Diseases
    • +3 more
      • Bari, BA, Italy
        Michele Barone
      May 17, 2022

      Solid Tumor Trial (HER2-E-CART cells)

      Not yet recruiting
      • Solid Tumor
      • HER2-E-CART cells
      • (no location specified)
      Feb 16, 2023

      Acute Respiratory Distress Syndrome Trial (Racecadotril 100 milligram (MG) Oral Capsule, Placebo)

      Not yet recruiting
      • Acute Respiratory Distress Syndrome
      • Racecadotril 100 milligram (MG) Oral Capsule
      • Placebo
      • (no location specified)
      Jan 13, 2023

      Acute Leukemias, Burkitt's Lymphoma, Chronic Myelogenous Leukemia Trial in Minneapolis (drug, radiation, biological)

      Terminated
      • Acute Leukemias
      • +2 more
      • Minneapolis, Minnesota
        University of Minnesota Masonic Cancer Center
      Dec 12, 2019

      Head Neck Cancer, Cervical Cancer, Non-small Cell Carcinoma Trial in Scottsdale, Chapel Hill (TSC-204-A0201, TSC-204-C0702,

      Not yet recruiting
      • Head and Neck Cancer
      • +20 more
      • TSC-204-A0201
      • +4 more
      • Scottsdale, Arizona
      • +1 more
      Aug 3, 2023

      The Effect of Human Prostate Tissue on Platelet Activation

      Completed
      • Prostate Hyperplasia
      • +2 more
        • (no location specified)
        Sep 19, 2021

        Ewing Sarcoma, Rhabdomyosarcoma, Synovial Sarcoma Trial in Frankfurt am Main, Freiburg, Tübingen (Peptide vaccine IPX)

        Recruiting
        • Ewing Sarcoma
        • +2 more
        • Peptide vaccine IPX
        • Frankfurt am Main, Germany
        • +2 more
        Oct 18, 2023

        Idiopathic Inflammatory Myopathies, Diffuse Cutaneous Systemic Sclerosis, SLE Nephritis Trial (KYV-101, Cyclophosphamide,

        Not yet recruiting
        • Idiopathic Inflammatory Myopathies
        • +3 more
        • (no location specified)
        Nov 21, 2023

        Nanomix eLab® COVID-19 Rapid Antigen Panel With Samples From

        Completed
        • Covid19
        • Nanomix eLab® COVID-19 Rapid Antigen Panel (non-interventional)
        • Emeryville, California
          Nanomix
        Dec 22, 2021

        Antibody-mediated Rejection, Cardiac Transplant Trial in Rochester (Daratumumab and hyaluronidase-fihj)

        Enrolling by invitation
        • Antibody-mediated Rejection
        • Cardiac Transplant
        • Daratumumab and hyaluronidase-fihj
        • Rochester, Minnesota
          Mayo Clinic Rochester
        Apr 11, 2022

        Lymphoma, B-Cell, Lymphoma, Non-hodgkins, Chronic Lymphocytic Leukemia Trial run by the NCI (Anti-cluster of differentiation 19

        Terminated
        • Lymphoma, B-Cell
        • +3 more
        • Anti-cluster of differentiation 19 (CD19)-Chimeric Antigen Receptors (CAR) and Anti-cluster of differentiation 20 (CD20)-CAR T cells
        • +2 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Jan 26, 2022

        Hematologic Malignancies Trial in Minneapolis (Haplo HCT <55 years old, Haplo HCT =55 years old, GVHD Prophylaxis)

        Recruiting
        • Hematologic Malignancies
        • Haplo HCT <55 years old
        • +4 more
        • Minneapolis, Minnesota
          Masonic Cancer Center at University of Minnesota
        Jan 25, 2023

        Advanced Solid Tumor Trial in Bethesda, Boston (STAR0602)

        Recruiting
        • Advanced Solid Tumor
        • Bethesda, Maryland
        • +1 more
        Jan 6, 2023

        SARS CoV 2 Infection, Influenza, Human Trial in Spain (BIMERVAX, SIIV)

        Not yet recruiting
        • SARS CoV 2 Infection
        • Influenza, Human
        • BIMERVAX
        • SIIV
        • Santiago De Compostela, A Coruña, Spain
        • +7 more
        Aug 8, 2023

        Hematologic Malignancy, Myeloid Malignancy Trial in Memphis (Ruxolitinib, Mesna, Anti-thymocyte globulin (ATG))

        Recruiting
        • Hematologic Malignancy
        • Myeloid Malignancy
        • Memphis, Tennessee
          St. Jude Children's Research Hospital
        Nov 7, 2022